A. Mackinnon, S. Khindri, N. Hirani, H. Leffler, U. Nilsson, T. Sethi, A. Pedersen, H. Schambye, C. McClinton, R. Slack, T. Maher
{"title":"Galactic-1:一项随机、双盲、多中心、平行、安慰剂对照的2b期研究,在特发性肺纤维化(IPF)患者中研究TD139的有效性和安全性,TD139是一种吸入式半乳糖凝集素-3抑制剂,通过干粉吸入器给药超过52周","authors":"A. Mackinnon, S. Khindri, N. Hirani, H. Leffler, U. Nilsson, T. Sethi, A. Pedersen, H. Schambye, C. McClinton, R. Slack, T. Maher","doi":"10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a3065","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":385960,"journal":{"name":"B34. ILD CELLULAR MECHANISMS","volume":"70 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Galactic-1: A Randomized, Double-Blind, Multicentre, Parallel, Placebo-Controlled Phase 2b Study in Subjects with Idiopathic Pulmonary Fibrosis (IPF) Investigating the Efficacy and Safety of TD139, an Inhaled Galectin-3 Inhibitor Administered via a Dry Powder Inhaler Over 52 Weeks\",\"authors\":\"A. Mackinnon, S. Khindri, N. Hirani, H. Leffler, U. Nilsson, T. Sethi, A. Pedersen, H. Schambye, C. McClinton, R. Slack, T. Maher\",\"doi\":\"10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a3065\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":385960,\"journal\":{\"name\":\"B34. ILD CELLULAR MECHANISMS\",\"volume\":\"70 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"B34. ILD CELLULAR MECHANISMS\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a3065\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"B34. ILD CELLULAR MECHANISMS","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a3065","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Galactic-1: A Randomized, Double-Blind, Multicentre, Parallel, Placebo-Controlled Phase 2b Study in Subjects with Idiopathic Pulmonary Fibrosis (IPF) Investigating the Efficacy and Safety of TD139, an Inhaled Galectin-3 Inhibitor Administered via a Dry Powder Inhaler Over 52 Weeks